Professor of medicine, geneticist, endocrinologist, head of Department of Genomic Medicine at Medical University of Warsaw and the Laboratory of Human Cancer Genetics at University of Warsaw. Co-founder of Warsaw Genomics, a diagnostic company which creates unique genomic tests that allow for personalized anti-cancer prophylaxis. In his research performed in USA and Poland he focused on identifying the molecular changes underlying heritability and pathogenesis of human cancers. He published several research papers with more than 3000 citations. He developed the proprietary method of genetic analysis, which decreased 20-fold the price of the multigene test. Due to this innovation he was able to start the National Cancer Risk Screening Program, which attracted over 50 000 people in the first year. The aim of the Program is to identify all the people predisposed to inherited cancers in entire Polish population, and introduce each person at risk into personalized prophylactic plan. He was honored by the National Award for Vision and Innovation by the Polish Business Roundtable (2017), Man of the Year in Science and Innovation Award by Readers of “Gazeta Wyborcza” Daily, and One of the Most Influential People in Polish Medicine Award by “Puls Medycyny” Weekly.